FBR believes the company is well positioned to change the way in which doctors treat women with hormone replacement therapy. TherapeuticsMD's is developing its TX-001 HR for treating post-menopausal vasomotor symptoms such as hot flashes.
The stock was up 15.01% to $4.75 at 10:36 a.m. More than 5.8 million shares had changed hands, compared to the average volume of 1,167,370.
Must Read: Warren Buffett's 25 Favorite StocksSTOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts